ArticleJournal of clinical medicine2021

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome-A Single Center Prospective Study.

Anna Matyjek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.